Project
Illumina Body Map 2
Navigation
Downloads
Results for WT1_MTF1_ZBTB7B
Z-value: 2.52
Motif logo
Transcription factors associated with WT1_MTF1_ZBTB7B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WT1
|
ENSG00000184937.8 | WT1 transcription factor |
|
MTF1
|
ENSG00000188786.9 | metal regulatory transcription factor 1 |
|
ZBTB7B
|
ENSG00000160685.9 | zinc finger and BTB domain containing 7B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZBTB7B | hg19_v2_chr1_+_154975110_154975149 | -0.66 | 3.6e-05 | Click! |
| MTF1 | hg19_v2_chr1_-_38325256_38325292 | -0.33 | 6.2e-02 | Click! |
| WT1 | hg19_v2_chr11_-_32452357_32452363 | 0.31 | 8.1e-02 | Click! |
Activity profile of WT1_MTF1_ZBTB7B motif
Sorted Z-values of WT1_MTF1_ZBTB7B motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr4_-_819901 | 21.62 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
| chr4_-_819880 | 20.51 |
ENST00000505203.1
|
CPLX1
|
complexin 1 |
| chr22_+_51112800 | 17.24 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
| chr19_-_291365 | 14.12 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr16_+_87636474 | 14.07 |
ENST00000284262.2
|
JPH3
|
junctophilin 3 |
| chr22_+_48972118 | 13.31 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
| chr14_+_102027688 | 12.97 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chr17_+_30593195 | 12.57 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr19_+_708910 | 12.49 |
ENST00000264560.7
|
PALM
|
paralemmin |
| chr19_+_709101 | 12.27 |
ENST00000338448.5
|
PALM
|
paralemmin |
| chr9_+_132934835 | 11.65 |
ENST00000372398.3
|
NCS1
|
neuronal calcium sensor 1 |
| chr11_-_12030681 | 11.52 |
ENST00000529338.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr11_-_12030629 | 11.50 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr19_-_18717627 | 11.49 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
| chr14_-_53417732 | 11.35 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr4_+_150999418 | 10.56 |
ENST00000296550.7
|
DCLK2
|
doublecortin-like kinase 2 |
| chr21_+_47063590 | 10.32 |
ENST00000400314.1
|
PCBP3
|
poly(rC) binding protein 3 |
| chr1_-_1475737 | 10.29 |
ENST00000378733.4
ENST00000425828.1 |
TMEM240
|
transmembrane protein 240 |
| chr16_+_58497567 | 10.26 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
| chr11_-_12030746 | 10.02 |
ENST00000533813.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr6_+_19837592 | 10.01 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| chr10_-_79397391 | 10.01 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr8_+_136469684 | 9.67 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
| chr4_-_5894777 | 9.66 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
| chr2_-_241759622 | 9.65 |
ENST00000320389.7
ENST00000498729.2 |
KIF1A
|
kinesin family member 1A |
| chr15_+_80696666 | 9.65 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
| chr2_+_220306745 | 9.59 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
| chr2_-_233792837 | 9.58 |
ENST00000373552.4
ENST00000409079.1 |
NGEF
|
neuronal guanine nucleotide exchange factor |
| chr4_-_6565315 | 9.57 |
ENST00000506140.1
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr12_+_58005204 | 9.49 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
| chr19_-_49944806 | 9.46 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
| chr17_+_37783453 | 9.25 |
ENST00000579000.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr2_+_14772810 | 9.15 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr4_+_1795012 | 9.15 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
| chr19_+_55795493 | 9.14 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr2_+_42275153 | 9.08 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
| chr6_-_11044509 | 8.90 |
ENST00000354666.3
|
ELOVL2
|
ELOVL fatty acid elongase 2 |
| chr14_+_33408449 | 8.85 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
| chr22_+_29279552 | 8.81 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
| chr22_-_38851205 | 8.79 |
ENST00000303592.3
|
KCNJ4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
| chr19_-_51071302 | 8.79 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
| chr19_-_460996 | 8.77 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
| chrX_-_152939133 | 8.74 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chrX_-_152939780 | 8.40 |
ENST00000370142.1
ENST00000393831.2 ENST00000447676.2 |
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chrX_-_152939252 | 8.35 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr7_-_140340576 | 8.34 |
ENST00000275884.6
ENST00000475837.1 |
DENND2A
|
DENN/MADD domain containing 2A |
| chr22_+_45898712 | 8.32 |
ENST00000455233.1
ENST00000348697.2 ENST00000402984.3 ENST00000262722.7 ENST00000327858.6 ENST00000442170.2 ENST00000340923.5 ENST00000439835.1 |
FBLN1
|
fibulin 1 |
| chr11_+_369804 | 8.22 |
ENST00000329962.6
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
| chr20_+_36531499 | 8.22 |
ENST00000373458.3
ENST00000373461.4 ENST00000373459.4 |
VSTM2L
|
V-set and transmembrane domain containing 2 like |
| chr20_+_34742650 | 8.16 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr16_+_1203194 | 8.11 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr20_-_62103862 | 8.08 |
ENST00000344462.4
ENST00000357249.2 ENST00000359125.2 ENST00000360480.3 ENST00000370224.1 ENST00000344425.5 ENST00000354587.3 ENST00000359689.1 |
KCNQ2
|
potassium voltage-gated channel, KQT-like subfamily, member 2 |
| chr12_+_133195356 | 8.08 |
ENST00000389110.3
ENST00000449132.2 ENST00000343948.4 ENST00000352418.4 ENST00000350048.5 ENST00000351222.4 ENST00000348800.5 ENST00000542301.1 ENST00000536121.1 |
P2RX2
|
purinergic receptor P2X, ligand-gated ion channel, 2 |
| chr6_+_1389989 | 8.02 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
| chr1_+_1950763 | 8.02 |
ENST00000378585.4
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta |
| chr14_+_69726656 | 8.00 |
ENST00000337827.4
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
| chr9_+_130374537 | 7.98 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
| chr5_+_1008910 | 7.97 |
ENST00000296849.5
ENST00000274150.4 ENST00000537972.1 |
NKD2
|
naked cuticle homolog 2 (Drosophila) |
| chr9_+_137979506 | 7.96 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
| chr1_-_31381528 | 7.92 |
ENST00000339394.6
|
SDC3
|
syndecan 3 |
| chr19_-_46476791 | 7.89 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
| chr14_-_102026643 | 7.86 |
ENST00000555882.1
ENST00000554441.1 ENST00000553729.1 ENST00000557109.1 ENST00000557532.1 ENST00000554694.1 ENST00000554735.1 ENST00000555174.1 ENST00000557661.1 |
DIO3OS
|
DIO3 opposite strand/antisense RNA (head to head) |
| chr1_+_6845384 | 7.83 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr14_-_105635090 | 7.83 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
| chr1_-_20812690 | 7.82 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr10_+_134000404 | 7.80 |
ENST00000338492.4
ENST00000368629.1 |
DPYSL4
|
dihydropyrimidinase-like 4 |
| chr22_+_51039098 | 7.79 |
ENST00000399912.1
ENST00000329492.3 ENST00000442429.2 ENST00000341339.4 |
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2 |
| chr16_+_58497587 | 7.79 |
ENST00000569404.1
ENST00000569539.1 ENST00000564126.1 ENST00000565304.1 ENST00000567667.1 |
NDRG4
|
NDRG family member 4 |
| chr16_-_325910 | 7.77 |
ENST00000359740.5
ENST00000316163.5 ENST00000431291.2 ENST00000397770.3 ENST00000397768.3 |
RGS11
|
regulator of G-protein signaling 11 |
| chr12_+_26111823 | 7.74 |
ENST00000381352.3
ENST00000535907.1 ENST00000405154.2 |
RASSF8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
| chr22_+_43808014 | 7.73 |
ENST00000334209.5
ENST00000443721.1 ENST00000414469.2 ENST00000439548.1 |
MPPED1
|
metallophosphoesterase domain containing 1 |
| chr11_-_12030905 | 7.73 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr19_-_7990991 | 7.70 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr16_-_49890016 | 7.68 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
| chr17_+_64961026 | 7.61 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
| chr5_+_131593364 | 7.54 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
| chr6_+_44238203 | 7.50 |
ENST00000451188.2
|
TMEM151B
|
transmembrane protein 151B |
| chr2_+_56411131 | 7.48 |
ENST00000407595.2
|
CCDC85A
|
coiled-coil domain containing 85A |
| chr12_+_50355647 | 7.48 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
| chr16_+_330581 | 7.46 |
ENST00000219409.3
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
| chr17_+_79989500 | 7.45 |
ENST00000306897.4
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
| chr19_-_47922373 | 7.44 |
ENST00000559524.1
ENST00000557833.1 ENST00000558555.1 ENST00000561293.1 ENST00000441740.2 |
MEIS3
|
Meis homeobox 3 |
| chr5_-_11904152 | 7.43 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr18_+_33877654 | 7.43 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr9_-_13279406 | 7.42 |
ENST00000546205.1
|
MPDZ
|
multiple PDZ domain protein |
| chr2_+_105471969 | 7.39 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr17_+_37783170 | 7.30 |
ENST00000254079.4
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr4_-_6474173 | 7.30 |
ENST00000382599.4
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr15_+_73976545 | 7.28 |
ENST00000318443.5
ENST00000537340.2 ENST00000318424.5 |
CD276
|
CD276 molecule |
| chr2_-_230579185 | 7.26 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
| chr3_+_181429704 | 7.25 |
ENST00000431565.2
ENST00000325404.1 |
SOX2
|
SRY (sex determining region Y)-box 2 |
| chr8_-_145911188 | 7.22 |
ENST00000540274.1
|
ARHGAP39
|
Rho GTPase activating protein 39 |
| chr17_+_42836329 | 7.20 |
ENST00000200557.6
|
ADAM11
|
ADAM metallopeptidase domain 11 |
| chr2_-_1748214 | 7.19 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
| chr12_-_120806960 | 7.17 |
ENST00000257552.2
|
MSI1
|
musashi RNA-binding protein 1 |
| chr19_-_821931 | 7.13 |
ENST00000359894.2
ENST00000520876.3 ENST00000519502.1 |
LPPR3
|
hsa-mir-3187 |
| chr4_-_5890145 | 7.08 |
ENST00000397890.2
|
CRMP1
|
collapsin response mediator protein 1 |
| chr10_-_125651258 | 7.07 |
ENST00000241305.3
|
CPXM2
|
carboxypeptidase X (M14 family), member 2 |
| chr19_-_47975106 | 7.06 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr8_-_144241432 | 7.00 |
ENST00000430474.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
| chr19_+_589893 | 6.99 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr10_+_124221036 | 6.98 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr19_-_47922750 | 6.90 |
ENST00000331559.5
|
MEIS3
|
Meis homeobox 3 |
| chr9_-_112083229 | 6.87 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
| chr14_+_69726864 | 6.87 |
ENST00000448469.3
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
| chr11_+_101981423 | 6.86 |
ENST00000531439.1
|
YAP1
|
Yes-associated protein 1 |
| chr7_+_128431444 | 6.86 |
ENST00000459946.1
ENST00000378685.4 ENST00000464832.1 ENST00000472049.1 ENST00000488925.1 |
CCDC136
|
coiled-coil domain containing 136 |
| chr10_-_134599556 | 6.85 |
ENST00000368592.5
|
NKX6-2
|
NK6 homeobox 2 |
| chr9_-_13279589 | 6.84 |
ENST00000319217.7
|
MPDZ
|
multiple PDZ domain protein |
| chr20_-_43438912 | 6.81 |
ENST00000541604.2
ENST00000372851.3 |
RIMS4
|
regulating synaptic membrane exocytosis 4 |
| chr14_+_69726968 | 6.81 |
ENST00000553669.1
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
| chr9_+_17579084 | 6.80 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
| chr11_-_46940074 | 6.80 |
ENST00000378623.1
ENST00000534404.1 |
LRP4
|
low density lipoprotein receptor-related protein 4 |
| chr16_+_226658 | 6.77 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
| chr5_-_11904100 | 6.77 |
ENST00000359640.2
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr8_-_144241664 | 6.75 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
| chr14_-_103987679 | 6.75 |
ENST00000553610.1
|
CKB
|
creatine kinase, brain |
| chr7_+_121513374 | 6.74 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr20_-_55841662 | 6.73 |
ENST00000395863.3
ENST00000450594.2 |
BMP7
|
bone morphogenetic protein 7 |
| chr19_+_50706866 | 6.73 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
| chr4_+_2061119 | 6.73 |
ENST00000423729.2
|
NAT8L
|
N-acetyltransferase 8-like (GCN5-related, putative) |
| chr15_-_83316254 | 6.70 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr19_+_11650709 | 6.70 |
ENST00000586059.1
|
CNN1
|
calponin 1, basic, smooth muscle |
| chr20_-_55841398 | 6.67 |
ENST00000395864.3
|
BMP7
|
bone morphogenetic protein 7 |
| chr1_-_6546001 | 6.67 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr15_-_74045088 | 6.65 |
ENST00000569673.1
|
C15orf59
|
chromosome 15 open reading frame 59 |
| chr7_-_44365020 | 6.63 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr6_-_46459099 | 6.62 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
| chr7_-_19157248 | 6.59 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
| chr8_+_27491572 | 6.58 |
ENST00000301904.3
|
SCARA3
|
scavenger receptor class A, member 3 |
| chr11_+_66045634 | 6.58 |
ENST00000528852.1
ENST00000311445.6 |
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2 |
| chr6_+_17393839 | 6.51 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr19_-_11591848 | 6.51 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
| chr3_-_183979251 | 6.50 |
ENST00000296238.3
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
| chr19_+_15218180 | 6.47 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
| chr19_+_7660716 | 6.46 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
| chr2_+_235860690 | 6.46 |
ENST00000416021.1
|
SH3BP4
|
SH3-domain binding protein 4 |
| chr8_+_30241995 | 6.45 |
ENST00000397323.4
ENST00000339877.4 ENST00000320203.4 ENST00000287771.5 |
RBPMS
|
RNA binding protein with multiple splicing |
| chr19_-_1237990 | 6.42 |
ENST00000382477.2
ENST00000215376.6 ENST00000590083.1 |
C19orf26
|
chromosome 19 open reading frame 26 |
| chr16_+_77822427 | 6.40 |
ENST00000302536.2
|
VAT1L
|
vesicle amine transport 1-like |
| chr10_-_7708918 | 6.39 |
ENST00000256861.6
ENST00000397146.2 ENST00000446830.2 ENST00000397145.2 |
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
| chr9_-_94712434 | 6.39 |
ENST00000375708.3
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2 |
| chr4_+_187065978 | 6.38 |
ENST00000227065.4
ENST00000502970.1 ENST00000514153.1 |
FAM149A
|
family with sequence similarity 149, member A |
| chr17_+_42836521 | 6.37 |
ENST00000535346.1
|
ADAM11
|
ADAM metallopeptidase domain 11 |
| chrX_+_149531524 | 6.34 |
ENST00000370401.2
|
MAMLD1
|
mastermind-like domain containing 1 |
| chr2_+_39893043 | 6.33 |
ENST00000281961.2
|
TMEM178A
|
transmembrane protein 178A |
| chr16_+_222846 | 6.32 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
| chr9_-_13279563 | 6.30 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
| chr16_+_25703274 | 6.29 |
ENST00000331351.5
|
HS3ST4
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
| chr17_-_74533963 | 6.29 |
ENST00000293230.5
|
CYGB
|
cytoglobin |
| chr9_+_140772226 | 6.28 |
ENST00000277551.2
ENST00000371372.1 ENST00000277549.5 ENST00000371363.1 ENST00000371357.1 ENST00000371355.4 |
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
| chr19_-_47975417 | 6.26 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr15_-_79103757 | 6.25 |
ENST00000388820.4
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
| chr17_+_37783197 | 6.23 |
ENST00000582680.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr17_+_31254892 | 6.20 |
ENST00000394642.3
ENST00000579849.1 |
TMEM98
|
transmembrane protein 98 |
| chr17_+_31255165 | 6.20 |
ENST00000578289.1
ENST00000439138.1 |
TMEM98
|
transmembrane protein 98 |
| chr19_-_51054299 | 6.17 |
ENST00000599957.1
|
LRRC4B
|
leucine rich repeat containing 4B |
| chr17_-_41910505 | 6.17 |
ENST00000398389.4
|
MPP3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) |
| chrX_+_152760397 | 6.16 |
ENST00000331595.4
ENST00000431891.1 |
BGN
|
biglycan |
| chr11_-_119293903 | 6.14 |
ENST00000580275.1
|
THY1
|
Thy-1 cell surface antigen |
| chr6_-_110500826 | 6.14 |
ENST00000265601.3
ENST00000447287.1 ENST00000444391.1 |
WASF1
|
WAS protein family, member 1 |
| chr6_-_35464817 | 6.12 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr20_-_41818536 | 6.12 |
ENST00000373193.3
ENST00000373198.4 ENST00000373201.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
| chr1_+_15250596 | 6.10 |
ENST00000361144.5
|
KAZN
|
kazrin, periplakin interacting protein |
| chr6_+_17393888 | 6.08 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr16_+_89894875 | 6.08 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
| chr15_-_71146480 | 6.08 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
| chr17_-_31404 | 6.07 |
ENST00000343572.7
|
DOC2B
|
double C2-like domains, beta |
| chr7_-_82073031 | 6.07 |
ENST00000356253.5
ENST00000423588.1 |
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr12_-_50297638 | 6.02 |
ENST00000320634.3
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
| chr12_+_51984657 | 6.02 |
ENST00000550891.1
|
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
| chr17_+_8924837 | 6.02 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
| chr7_-_82073109 | 6.00 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr17_+_31255023 | 6.00 |
ENST00000395149.2
ENST00000261713.4 |
TMEM98
|
transmembrane protein 98 |
| chr19_+_3224700 | 5.99 |
ENST00000292672.2
ENST00000541430.2 |
CELF5
|
CUGBP, Elav-like family member 5 |
| chr14_+_94640633 | 5.98 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr8_-_133493200 | 5.94 |
ENST00000388996.4
|
KCNQ3
|
potassium voltage-gated channel, KQT-like subfamily, member 3 |
| chrX_+_38420623 | 5.92 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr7_+_75911902 | 5.92 |
ENST00000413003.1
|
SRRM3
|
serine/arginine repetitive matrix 3 |
| chr22_-_44258360 | 5.91 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chr19_-_291133 | 5.90 |
ENST00000327790.3
|
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr15_+_80987617 | 5.89 |
ENST00000258884.4
ENST00000558464.1 |
ABHD17C
|
abhydrolase domain containing 17C |
| chr21_+_47401650 | 5.89 |
ENST00000361866.3
|
COL6A1
|
collagen, type VI, alpha 1 |
| chr16_+_86544113 | 5.85 |
ENST00000262426.4
|
FOXF1
|
forkhead box F1 |
| chr14_+_29236269 | 5.84 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
| chr1_-_22263790 | 5.81 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr9_+_139873264 | 5.80 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr17_+_73717516 | 5.78 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
| chr2_-_110371664 | 5.78 |
ENST00000545389.1
ENST00000423520.1 |
SEPT10
|
septin 10 |
| chr11_+_101981169 | 5.77 |
ENST00000526343.1
ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1
|
Yes-associated protein 1 |
| chr19_+_45409011 | 5.77 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr11_+_43964055 | 5.76 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
| chr20_-_62130474 | 5.76 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr11_+_8040739 | 5.76 |
ENST00000534099.1
|
TUB
|
tubby bipartite transcription factor |
| chr14_+_100259666 | 5.74 |
ENST00000262233.6
ENST00000334192.4 |
EML1
|
echinoderm microtubule associated protein like 1 |
| chr5_+_9546306 | 5.74 |
ENST00000508179.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chr9_+_132427883 | 5.73 |
ENST00000372469.4
|
PRRX2
|
paired related homeobox 2 |
| chr12_+_121078355 | 5.73 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
| chr7_-_45128472 | 5.71 |
ENST00000490531.2
|
NACAD
|
NAC alpha domain containing |
| chr20_+_1206679 | 5.71 |
ENST00000402452.1
ENST00000409241.1 ENST00000381882.2 ENST00000246108.3 |
RAD21L1
|
RAD21-like 1 (S. pombe) |
Network of associatons between targets according to the STRING database.
First level regulatory network of WT1_MTF1_ZBTB7B
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.1 | 48.9 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 5.6 | 16.7 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 4.5 | 31.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 4.0 | 16.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 4.0 | 16.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 3.8 | 11.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 3.7 | 22.0 | GO:0030421 | defecation(GO:0030421) |
| 3.6 | 10.9 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 3.6 | 3.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 3.5 | 14.0 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 3.5 | 10.4 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 3.4 | 13.4 | GO:1905069 | allantois development(GO:1905069) |
| 3.3 | 13.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 3.2 | 6.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 3.1 | 34.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 3.1 | 27.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 3.0 | 18.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 3.0 | 9.1 | GO:0060596 | mammary placode formation(GO:0060596) |
| 3.0 | 6.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 3.0 | 6.0 | GO:0060214 | endocardium formation(GO:0060214) |
| 2.9 | 14.6 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
| 2.9 | 11.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 2.9 | 8.7 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 2.7 | 8.2 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 2.7 | 13.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.7 | 35.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.6 | 7.9 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 2.6 | 2.6 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 2.6 | 7.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 2.6 | 10.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.5 | 22.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 2.5 | 7.5 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 2.5 | 2.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 2.4 | 7.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 2.4 | 11.9 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 2.4 | 7.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 2.4 | 11.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 2.3 | 4.6 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 2.3 | 16.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 2.3 | 6.9 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 2.3 | 4.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 2.3 | 6.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 2.3 | 18.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 2.2 | 6.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 2.2 | 2.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 2.2 | 11.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 2.2 | 15.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 2.2 | 13.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 2.2 | 4.4 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 2.1 | 8.4 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 2.1 | 8.3 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 2.0 | 12.2 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 2.0 | 18.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 2.0 | 2.0 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 2.0 | 4.0 | GO:0060594 | mammary gland specification(GO:0060594) |
| 2.0 | 23.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 2.0 | 4.0 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 1.9 | 5.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 1.9 | 27.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.9 | 9.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.9 | 5.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 1.9 | 15.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 1.9 | 3.8 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 1.9 | 9.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 1.9 | 11.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 1.9 | 5.7 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 1.9 | 9.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 1.9 | 5.6 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 1.9 | 11.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 1.9 | 9.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 1.9 | 9.3 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) epinephrine secretion(GO:0048242) |
| 1.9 | 5.6 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.9 | 7.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 1.8 | 7.4 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 1.8 | 16.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.8 | 38.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 1.8 | 3.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 1.8 | 7.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.8 | 15.9 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 1.8 | 5.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 1.8 | 35.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.7 | 12.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 1.7 | 19.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.7 | 8.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.7 | 5.2 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
| 1.7 | 8.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.7 | 5.2 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.7 | 5.1 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 1.7 | 5.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.7 | 5.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.7 | 18.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.7 | 13.5 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 1.7 | 16.9 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 1.7 | 1.7 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 1.7 | 1.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 1.7 | 5.0 | GO:0050894 | determination of affect(GO:0050894) |
| 1.6 | 6.6 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 1.6 | 4.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 1.6 | 19.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 1.6 | 6.5 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 1.6 | 3.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 1.6 | 1.6 | GO:0003193 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 1.6 | 3.2 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 1.6 | 11.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 1.6 | 8.1 | GO:0048749 | compound eye development(GO:0048749) |
| 1.6 | 1.6 | GO:0042637 | catagen(GO:0042637) regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
| 1.6 | 1.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 1.6 | 1.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.6 | 6.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.6 | 3.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 1.6 | 6.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 1.5 | 9.2 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.5 | 6.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.5 | 1.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 1.5 | 4.5 | GO:1903947 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 1.5 | 7.4 | GO:0030070 | insulin processing(GO:0030070) |
| 1.5 | 17.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 1.5 | 10.4 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.5 | 4.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 1.5 | 10.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 1.5 | 4.4 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 1.5 | 24.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.5 | 2.9 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.5 | 4.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.5 | 5.8 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 1.5 | 4.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.4 | 10.1 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 1.4 | 4.3 | GO:0048627 | myoblast development(GO:0048627) |
| 1.4 | 1.4 | GO:0021854 | hypothalamus development(GO:0021854) |
| 1.4 | 4.3 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 1.4 | 5.7 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.4 | 7.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 1.4 | 5.6 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 1.4 | 1.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 1.4 | 13.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.4 | 4.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 1.4 | 2.7 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 1.3 | 4.0 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 1.3 | 9.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 1.3 | 6.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.3 | 5.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.3 | 6.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 1.3 | 6.6 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.3 | 15.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 1.3 | 4.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 1.3 | 5.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.3 | 5.2 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.3 | 1.3 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
| 1.3 | 1.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 1.3 | 16.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 1.3 | 3.9 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
| 1.3 | 1.3 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 1.3 | 1.3 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 1.3 | 7.6 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.3 | 17.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 1.3 | 3.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.3 | 1.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 1.3 | 15.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 1.3 | 11.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 1.2 | 3.7 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 1.2 | 2.5 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 1.2 | 4.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 1.2 | 1.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 1.2 | 3.6 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 1.2 | 3.6 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.2 | 12.0 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.2 | 9.6 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
| 1.2 | 1.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.2 | 2.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.2 | 3.5 | GO:0033058 | directional locomotion(GO:0033058) |
| 1.2 | 2.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.2 | 9.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.2 | 4.6 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 1.1 | 4.6 | GO:0060306 | regulation of membrane repolarization(GO:0060306) regulation of membrane repolarization during action potential(GO:0098903) |
| 1.1 | 5.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.1 | 12.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 1.1 | 3.4 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.1 | 4.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 1.1 | 13.6 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 1.1 | 3.4 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.1 | 5.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.1 | 12.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.1 | 9.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 1.1 | 11.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.1 | 7.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 1.1 | 15.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 1.1 | 3.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 1.1 | 9.8 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 1.1 | 2.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.1 | 5.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 1.1 | 17.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.1 | 9.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.1 | 9.7 | GO:0046958 | nonassociative learning(GO:0046958) |
| 1.1 | 1.1 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
| 1.1 | 3.2 | GO:1904170 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 1.1 | 5.4 | GO:0001757 | somite specification(GO:0001757) |
| 1.1 | 2.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 1.1 | 8.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.1 | 2.1 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 1.1 | 3.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 1.1 | 1.1 | GO:0072011 | glomerular endothelium development(GO:0072011) |
| 1.1 | 4.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 1.1 | 10.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.1 | 10.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.0 | 1.0 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 1.0 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.0 | 7.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.0 | 18.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 1.0 | 2.1 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.0 | 5.2 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.0 | 18.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.0 | 2.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 1.0 | 15.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 1.0 | 6.1 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.0 | 5.1 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 1.0 | 5.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.0 | 13.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.0 | 10.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 1.0 | 3.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 1.0 | 10.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 1.0 | 6.0 | GO:0032341 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) |
| 1.0 | 3.0 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 1.0 | 9.0 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 1.0 | 1.0 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 1.0 | 4.9 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.0 | 4.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.0 | 4.9 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.0 | 2.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 1.0 | 1.0 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 1.0 | 10.7 | GO:0051610 | serotonin uptake(GO:0051610) |
| 1.0 | 8.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 1.0 | 2.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 1.0 | 4.8 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.0 | 8.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 1.0 | 3.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.0 | 49.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.9 | 4.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.9 | 4.7 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.9 | 2.8 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.9 | 1.9 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.9 | 2.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.9 | 15.9 | GO:0035878 | nail development(GO:0035878) |
| 0.9 | 5.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.9 | 3.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.9 | 1.9 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.9 | 1.8 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.9 | 13.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.9 | 5.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.9 | 3.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 | 0.9 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.9 | 9.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.9 | 51.3 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.9 | 3.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.9 | 3.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.9 | 5.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.9 | 1.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.9 | 1.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.9 | 6.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.9 | 5.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.9 | 2.7 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.9 | 1.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.9 | 6.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.9 | 3.5 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.9 | 21.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.9 | 4.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.9 | 5.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.9 | 7.9 | GO:0003383 | apical constriction(GO:0003383) |
| 0.9 | 8.7 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.9 | 9.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.9 | 3.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.9 | 15.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.9 | 3.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.9 | 2.6 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.9 | 4.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.9 | 1.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.8 | 2.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.8 | 36.5 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.8 | 2.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.8 | 2.5 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.8 | 5.8 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.8 | 2.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.8 | 1.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.8 | 5.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.8 | 2.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.8 | 3.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.8 | 0.8 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.8 | 3.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.8 | 3.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.8 | 4.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.8 | 6.3 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.8 | 2.4 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.8 | 2.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.8 | 3.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.8 | 4.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.8 | 15.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.8 | 9.4 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.8 | 1.6 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) negative regulation of gastrulation(GO:2000542) |
| 0.8 | 2.3 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.8 | 2.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.8 | 10.9 | GO:0060068 | vagina development(GO:0060068) |
| 0.8 | 2.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.8 | 6.1 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.8 | 0.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.8 | 3.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.8 | 3.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 | 3.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.8 | 1.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.8 | 2.3 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.8 | 3.0 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.7 | 0.7 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.7 | 0.7 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.7 | 2.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.7 | 8.1 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.7 | 0.7 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.7 | 21.9 | GO:0033622 | integrin activation(GO:0033622) |
| 0.7 | 2.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.7 | 0.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.7 | 4.3 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.7 | 2.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.7 | 1.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 | 2.2 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.7 | 2.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.7 | 2.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
| 0.7 | 7.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.7 | 4.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.7 | 5.0 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.7 | 7.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.7 | 19.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.7 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.7 | 9.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.7 | 2.8 | GO:0021794 | thalamus development(GO:0021794) |
| 0.7 | 11.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.7 | 2.8 | GO:0042335 | cuticle development(GO:0042335) |
| 0.7 | 7.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.7 | 0.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.7 | 2.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.7 | 4.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.7 | 0.7 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.7 | 4.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.7 | 15.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.7 | 14.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.7 | 1.4 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.7 | 1.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.7 | 2.7 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.7 | 4.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.7 | 16.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.7 | 1.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.7 | 2.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.7 | 2.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.7 | 0.7 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.7 | 17.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.7 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.7 | 5.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.7 | 2.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.7 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.7 | 3.3 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.7 | 6.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.7 | 1.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.7 | 2.0 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.7 | 0.7 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 0.7 | 6.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.7 | 5.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.7 | 8.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.7 | 5.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.7 | 3.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.7 | 3.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.6 | 1.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.6 | 0.6 | GO:0072033 | renal vesicle formation(GO:0072033) |
| 0.6 | 6.4 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.6 | 1.9 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.6 | 3.2 | GO:0015862 | uridine transport(GO:0015862) |
| 0.6 | 1.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.6 | 1.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.6 | 10.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.6 | 3.8 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.6 | 3.8 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.6 | 4.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 | 48.6 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
| 0.6 | 3.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.6 | 6.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.6 | 5.0 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.6 | 0.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.6 | 5.0 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.6 | 11.1 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.6 | 2.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.6 | 7.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 | 1.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.6 | 1.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.6 | 7.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.6 | 6.0 | GO:0015820 | leucine transport(GO:0015820) |
| 0.6 | 9.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.6 | 1.8 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.6 | 3.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.6 | 10.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.6 | 6.5 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.6 | 4.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.6 | 6.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telome |